MXPA03007024A - Enlace de endotoxina por bacteria y bifidobacteria de acido lactico. - Google Patents

Enlace de endotoxina por bacteria y bifidobacteria de acido lactico.

Info

Publication number
MXPA03007024A
MXPA03007024A MXPA03007024A MXPA03007024A MXPA03007024A MX PA03007024 A MXPA03007024 A MX PA03007024A MX PA03007024 A MXPA03007024 A MX PA03007024A MX PA03007024 A MXPA03007024 A MX PA03007024A MX PA03007024 A MXPA03007024 A MX PA03007024A
Authority
MX
Mexico
Prior art keywords
bifidobacteria
lactic acid
acid bacteria
endotoxin binding
endotoxin
Prior art date
Application number
MXPA03007024A
Other languages
English (en)
Inventor
Guillermo Kociubinski
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8179863&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA03007024(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of MXPA03007024A publication Critical patent/MXPA03007024A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
MXPA03007024A 2001-02-06 2002-02-01 Enlace de endotoxina por bacteria y bifidobacteria de acido lactico. MXPA03007024A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01200436 2001-02-06
PCT/EP2002/001163 WO2002062360A1 (en) 2001-02-06 2002-02-01 Endotoxin binding by lactic acid bacteria and bifidobacteria

Publications (1)

Publication Number Publication Date
MXPA03007024A true MXPA03007024A (es) 2003-11-18

Family

ID=8179863

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03007024A MXPA03007024A (es) 2001-02-06 2002-02-01 Enlace de endotoxina por bacteria y bifidobacteria de acido lactico.

Country Status (21)

Country Link
US (2) US7550285B2 (es)
EP (1) EP1359924B1 (es)
JP (3) JP2004531477A (es)
KR (1) KR100845456B1 (es)
CN (1) CN1250232C (es)
AT (1) ATE375164T1 (es)
AU (1) AU2002250886B2 (es)
BR (1) BR0207019A (es)
CA (1) CA2436264C (es)
DE (1) DE60222856T2 (es)
EA (1) EA006397B1 (es)
ES (1) ES2292744T3 (es)
HK (1) HK1066174A1 (es)
IL (1) IL157071A0 (es)
MX (1) MXPA03007024A (es)
NO (1) NO20033372L (es)
NZ (1) NZ527493A (es)
PL (1) PL367083A1 (es)
PT (1) PT1359924E (es)
WO (1) WO2002062360A1 (es)
ZA (1) ZA200306935B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA006397B1 (ru) * 2001-02-06 2005-12-29 Сосьете Де Продюи Нестле С.А. Связывающие эндотоксин штаммы лактобактерий и бифидобактерий, обладающие гидрофобными свойствами, и способы их применения
FR2848115B1 (fr) * 2002-12-05 2005-03-25 Rhodia Chimie Sa Composition de bacteries et son utilisation
SE526711C2 (sv) * 2003-01-31 2005-10-25 Probi Ab Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
US7303745B2 (en) 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
EP2261323A1 (en) 2005-05-31 2010-12-15 The Iams Company Feline probiotic lactobacilli
PL1885383T3 (pl) 2005-05-31 2017-06-30 Iams Europe B.V. Kocie probiotyczne bifidobakterie
US20090083067A1 (en) * 2006-03-29 2009-03-26 Mary Elaine Freeland Methods and kits for selecting a health care product
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
WO2008106372A1 (en) * 2007-02-28 2008-09-04 Mead Johnson Nutrition Company Method for treating or preventing systemic inflammation
KR100913406B1 (ko) * 2008-03-25 2009-08-21 광주과학기술원 Ｔｈ１－매개 면역 질환의 예방 또는 치료용 조성물
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
BR112012001812B1 (pt) * 2009-07-30 2019-04-16 Dupont Nutrition Biosciences Aps Uso de bactéria para o tratamento da endotoxemiametabólica em mamífero
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2011069860A1 (en) 2009-12-08 2011-06-16 Chr. Hansen A/S Novel use for the treatment of metabolic endotoxemia
JP2010280664A (ja) * 2010-07-02 2010-12-16 Biogaia Ab ラクトバチルス・リューテリ（Ｌａｃｔｏｂａｃｉｌｌｕｓｒｅｕｔｅｒｉ）株を用いる哺乳類における免疫機能の改善方法
JP2014520548A (ja) 2011-07-13 2014-08-25 フリースランド・ブランズ・ビー・ブイ 低いｌｐｓを有する乳製品をベースとした組成物
US20130022586A1 (en) * 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
CN104780932A (zh) 2012-02-29 2015-07-15 伊西康内外科公司 微生物区系的组合物及与其相关的方法
US20150093462A1 (en) * 2013-09-30 2015-04-02 Elc Management Llc Watery Lotion Skin Care Compositions And Methods
EP3212001A4 (en) 2014-10-31 2018-04-25 Whole Biome Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
CN104498375B (zh) * 2014-12-02 2017-05-10 江南大学 一株具有内毒素吸附特性的耶氏酵母及其吸附特性研究方法
JP6710075B2 (ja) * 2016-03-29 2020-06-17 カゴメ株式会社 Ｌｐｓ産生抑制剤、及びｌｐｓ産生抑制用の食品組成物
TWI640319B (zh) * 2017-05-12 2018-11-11 健茂生物科技股份有限公司 具有抗發炎活性之醱酵液的製備方法
CN111372596A (zh) 2017-08-30 2020-07-03 潘德勒姆治疗公司 用于治疗微生物组相关病症的方法和组合物
JP6888145B2 (ja) * 2020-03-23 2021-06-16 カゴメ株式会社 Ｌｐｓ産生抑制剤、及びｌｐｓ産生抑制用の食品組成物
WO2021253017A2 (en) * 2020-06-07 2021-12-16 Ramasamy Sundaram Compositions and methods for detoxifying bacterial endotoxins and hydrogen sulfide by recombinant fusion enzymes
CN116096856A (zh) 2020-08-28 2023-05-09 科·汉森有限公司 利用辛烯基琥珀酸酐淀粉-壳聚糖复合团聚体微囊化微生物培养物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US555618A (en) * 1896-03-03 Hay-loader
IT1254210B (it) * 1992-02-10 1995-09-14 Simone Claudio De Composizioni dietetiche e/o farmaceutiche a base di batteri lattici liofilizzati, loro preparazione e impiego
US5413785A (en) * 1993-01-27 1995-05-09 New England Deaconess Hospital Corp. Methodology employing lactobacillus GG for reduction of plasma endotoxin levels circulating in-vivo
JP2506314B2 (ja) * 1993-10-27 1996-06-12 全国農業協同組合連合会 家禽・豚の敗血症の予防・治療剤及び飼料
US6506389B2 (en) * 1995-10-20 2003-01-14 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (Tno) Adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
ATE206873T1 (de) * 1997-01-09 2001-11-15 Nestle Sa Probiotik enthaltendes getreideprodukt
JP4163276B2 (ja) * 1998-02-05 2008-10-08 独立行政法人理化学研究所 機能性組成物
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
KR20010101171A (ko) * 1998-12-11 2001-11-14 추후기재 비뇨생식기 감염의 치료 및 예방을 위한 락토바실러스의경구 투여
AU783439C (en) * 2000-03-24 2006-12-14 Societe Des Produits Nestle S.A. Use of lactic acid bacterium for the prevention of peritonitis
EA006397B1 (ru) * 2001-02-06 2005-12-29 Сосьете Де Продюи Нестле С.А. Связывающие эндотоксин штаммы лактобактерий и бифидобактерий, обладающие гидрофобными свойствами, и способы их применения

Also Published As

Publication number Publication date
EP1359924A1 (en) 2003-11-12
NO20033372D0 (no) 2003-07-28
PL367083A1 (en) 2005-02-21
JP5973701B2 (ja) 2016-08-23
US20040115178A1 (en) 2004-06-17
US7550285B2 (en) 2009-06-23
IL157071A0 (en) 2004-02-08
KR100845456B1 (ko) 2008-07-10
PT1359924E (pt) 2007-12-07
NZ527493A (en) 2005-06-24
CA2436264A1 (en) 2002-08-15
JP2004531477A (ja) 2004-10-14
DE60222856T2 (de) 2008-07-24
WO2002062360A1 (en) 2002-08-15
KR20030076652A (ko) 2003-09-26
EP1359924B1 (en) 2007-10-10
JP2011246483A (ja) 2011-12-08
JP2014062104A (ja) 2014-04-10
HK1066174A1 (en) 2005-03-18
AU2002250886B2 (en) 2007-08-02
EA006397B1 (ru) 2005-12-29
BR0207019A (pt) 2004-02-25
CA2436264C (en) 2014-01-28
ZA200306935B (en) 2004-12-06
ES2292744T3 (es) 2008-03-16
CN1501805A (zh) 2004-06-02
NO20033372L (no) 2003-07-28
EA200300862A1 (ru) 2003-12-25
DE60222856D1 (de) 2007-11-22
US7964384B2 (en) 2011-06-21
US20100136662A1 (en) 2010-06-03
ATE375164T1 (de) 2007-10-15
CN1250232C (zh) 2006-04-12

Similar Documents

Publication Publication Date Title
IL157071A0 (en) Endotoxine binding by lactic acid bacteria and bifidobacteria
WO2002007533A3 (en) Nutritional composition
IL147271A0 (en) Compounds that bind her2
WO2001052667A3 (en) Pet food composition for treating helicobacter species in pets
WO2005110445A3 (en) Methods and compositions for the dietary management of autoimmune disorders
MXPA06000318A (es) Pano limpiador y metodos para mejorar la salud de la piel.
WO2002058712A3 (en) Probiotic compounds derived from lactobacillus casei strain ke01
WO2006082328A3 (fr) Compositions comprenant des micro-organismes deshydrates, leurs procedes de preparation, et leurs utilisations
WO2008148873A3 (en) Hydroxyproline compositions and uses thereof
MXPA04005583A (es) Composicion para la promocion del crecimiento oseo y mantenimiento de la salud osea.
EP1759597A3 (en) Probiotic composition
MY148286A (en) Freeze-dried, aerated dairy or dairy-substitute compositions and methods of making thereof
WO2001015715A3 (en) Composition for maintenance of bone or dental health or treatment of bone or dental disorders
EP1800691A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
IL161995A (en) Purified strain of lactic acid bacterium and uses thereof in the preparation of edible compositions, drugs and veterinary products
WO2007015132A3 (en) Use of specific lactic bacteria for the preparation of immunomodulating compositions
WO2003053474A3 (en) Use of micro-organisms for a directed delivery of substances to specific parts of the gut
WO2009057287A1 (ja) 破骨細胞形成抑制用食品素材
PL346143A1 (en) Tan-1057 derivatives
WO2002081521A8 (en) Osteoprotegerin in milk
WO2009057282A1 (ja) 骨吸収抑制用食品素材
WO2002069944A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und nk1-rezeptor-antagonisten
PL1615656T3 (pl) Produkt immunomodulatorowy otrzymany z hodowli bifidobacterium i zawierające go kompozycje
WO2003026693A3 (en) Inhibitors of costimulation by 0x40 and their use against infectious diseases
TW200602057A (en) Medicaments containing n-sulfamoyl-n' -arylpiperazines for the prophylaxis or treatment of obesity and related conditions

Legal Events

Date Code Title Description
FG Grant or registration